Di Grazia C

Title : Day100 Score predicts moderate-severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation - Metafuni_2021_Blood.Adv__

Author(s) : Metafuni E , Cavattoni IM , Lamparelli T , Raiola AM , Ghiso A , Galaverna F , Gualandi F , Di Grazia C , Dominietto A , Varaldo R , Signori A , Chiusolo P , Sora F , Giammarco S , Laurenti L , Sica S , Angelucci E , Bacigalupo A

Ref : Blood Adv , : , 2021

Abstract :

PubMedSearch : Metafuni_2021_Blood.Adv__

PubMedID: 34920451

Title : Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM) - Bacigalupo_2001_Bone.Marrow.Transplant_28_1041

Author(s) : Bacigalupo A , Oneto R , Bruno B , Lamparelli T , Gualandi F , Bregante S , Raiola AM , Di Grazia C , Dominietto A , Lombardi A , Frassoni F , Van Lint MT

Ref : Bone Marrow Transplant , 28 :1041 , 2001

Abstract :

PubMedSearch : Bacigalupo_2001_Bone.Marrow.Transplant_28_1041

PubMedID: 11781614

Di Grazia C

References (2)

1. Day100 Score predicts moderate-severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation - Metafuni_2021_Blood.Adv__

2. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM) - Bacigalupo_2001_Bone.Marrow.Transplant_28_1041